Patients should work with registered dietitians to establish sustainable eating patterns before discontinuation
Wegovy, Oral Wegovy, Zepbound, and Foundayo are poised to support your journey to effective weight management
Novel properties of old propranolol-assessment of antiglycation activity through in vitro and in silico approaches
A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
Key Takeaways Retatrutide activates GLP-1R, GIPR, and GCGR simultaneously, making it structurally distinct from both semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP only)